The protein mitoNEET (mNT) is a protein first described in 2004 that binds the type- 2 diabetes drug pioglitazone. The homodimeric protein is encoded by the gene CISD1 and has been implicated to play still undefined role(s) in type-2 diabetes and Parkinson's Disease. Like all NEET proteins, the mNT monomer possesses a CDGSH domain with three cysteine and one histidine residue coordinating a [2Fe-2S] cluster. Removal of this cluster by treatment with acidic conditions induces mNT unfolding. While there are numerous crystal structures in the Protein Data Bank, little is known about holo mNT dynamics and stability or the unfolding of apo mNT. Here we apply hydrogen exchange mass spectrometry (HXMS) to holo and apo mNT to detect dynamics ranging from local breathing to global unfolding under native-state conditions. With mild shifts in pH and temperature, our N-HXMS approach can detect partially unfolded intermediates, extract the free energy of unfolding and/or the rate constants of unfolding and folding for the native state and intermediates. In addition, we can simultaneously monitor holo and apo states of mNT due to their differences in mass. By systematically comparing their HXMS behavior, we will gain insight into the connection between mNT dynamics and function.
Read full abstract